Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(1118)
•••
Comment by Hempdocon Sep 03, 2020 4:51pm
155 Views
Post# 31507811

RE:RE:RE:Sad

RE:RE:RE:Sad
Bunge wrote:
Hempdoc wrote:

 

Bunge wrote:
Extra sad over TLT today for some reason.

July 2019: $120,000

Sept 2020: $35,000

- $85,000



Waiting 7 years and some lucky joker will eventually buy 200,000 shares and get a 10X bagger in 3 months. :P

MAYBE. HOPEFULLY.

 

 

Added 50K shares today Bunge....I guess I'm a loser & a sucker...no disclaimer needed ; P



NO. Maybe you're the lucky guy that will get the 10X bagger by December without having to wait a decade!


 

Would be nice...I'm certainly not investing in mgmt, but I just can't miss shopping for quality merchandise at a marked down price (TLD-1433 + promising biosimilars).  Knowing what we have (notwithstanding mgmt), I get a little more greedy when others are fearful : ).   Our compound & all of its derivatives should be in good/more steady hands moving forward, especially externally... it's nice to have reputable & independent investigators shine new (& possibly brighter) lights on what could be & likely will imo.

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities